Daily Program

본문 바로가기

팝업레이어 알림

팝업레이어 알림이 없습니다.

  Daily Program
SBiS 2020 : A Decade of Building a Global Korean Vascular Network
쉐라톤 서울 팔래스 강남 호텔 다이너스티홀
08:30-08:50
Registration
사회: 박형섭 (서울의대)
 
08:50-08:55
Opening Address
Ku Yong Jeong (Ewha Womans Univ.)
정구용 (이화의대)
08:55-09:00
Course review
Taeseung Lee (Seoul National Univ.)
이태승 (서울의대)
Session 1. LIVE connection with USA (I)
09:00-10:30
Moderators:
Taeseung Lee (Seoul National Univ.)
이태승 (서울의대)
Hyung Sub Park (Seoul National Univ.)
박형섭 (서울의대)

09:00-09:15
Recorded live case 1: Transcarotid Arterial Revascularization (TCAR)
Jae S Cho (Case Western Reserve Univ., USA)
 
09:15-09:30
Recorded live case 2: In-Situ FEVAR for ruptured unstable TAAA
Sukgu M Han (Univ. of Southern California, USA)
 
09:30-09:45
Vascular surgeon's role during the COVID-19 pandemic: experience in the heart of NY
Daniel K. Han (Mount Sinai Univ., USA)
 
09:45-10:00
Perioperative thromboprophylaxis in COVID-19 patients
Cheong Jun Lee (Northshore Univ., USA)
 
10:00-10:15
BMT vs CEA vs CAS in asymptomatic carotid disease patients
Jae S Cho (Case Western Reserve Univ., USA)
 
10:15-10:30
Customized FEVAR/BEVAR vs PMEG
William J Yoon (UC Davis, USA)
 
10:30-10:50
Coffee break
Session 2. LIVE connection with USA (II)
10:50-12:20
Moderators:
Seung Kee Min (Seoul National Univ.)
민승기 (서울의대)
Sang-il Min (Seoul National Univ.)
민상일 (서울대학교병원)

10:50-11:05
Bridging covered stents during FEVAR/BEVAR: which is best and why?
William J Yoon (UC Davis, USA)
 
11:05-11:20
Neoaortoiliac System (NAIS) Procedure for Infected Aortic Graft Treatment
Jayer Chung (Baylor Univ., USA)
 
11:20-11:35
DCB/DES use in claudicants vs critical limb ischemia patients: should they differ?
Cheong Jun Lee (Northshore Univ., USA)
 
11:35-11:50
Guideline-based role of surgery in PAD: Will the BASIL-2 and BEST-CLI trials be a game changer?
Jayer Chung (Baylor Univ., USA)
 
11:50-12:20
Debate: The current status of the endovascular drive in thoracoabdominal aorta pathology
1. Deviating from the endo track (back to open)
Suk Won Song (Yonsei Univ.)
송석원 (연세의대)
2. Still in track with some minor bumps (endo favored)
Sukgu M Han (Univ. of Southern California, USA)
 
Special Session. LUNCHEON (Sponsored by BD Bard)
12:30-13:30
Moderators:
Jongwon Ha (Seoul National Univ.)
하종원 (서울의대)

12:30-13:30
Recorded lecture: Optimize Venous Stenting Outcomes : 24 month Vernacular Trial Results & Lessons Learned from the Expert on Venous Stenting
Paul Gagne (Norwalk Hospital)
 
Session 3. Deep venous intervention: In Depth
13:30-14:50
Moderators:
In Mok Jung (Seoul National Univ.)
정인목 (서울의대)
Sang Woo Park (Konkuk Univ.)
박상우 (건국의대)

13:30-13:40
Recorded live case 3: PMEG for TAAA
13:40-13:50
Limitations of the CAVENT, ATTRACT and CAVA trials: Is anticoagulation alone enough for acute DVT
Young Sun Yoo (Chosun Univ.)
유영선 (조선의대)
13:50-14:00
Advantages of pharmacomechanical thrombectomy for deep vein thrombosis
Sang Woo Park (Konkuk Univ.)
박상우 (건국의대)
14:00-14:10
Thrombotic vs nonthrombotic iliocaval obstruction: Management strategies for CVI intervention
Hyung Sub Park (Seoul National Univ.)
박형섭 (서울의대)
14:10-14:20
Medical management after deep venous stenting
Keun Myoung Park (Inha Univ.)
박근명 (인하의대)
14:20-14:30
Can all chronically occluded IVC filters be removed? Tips and tricks
Je Hwan Won (Ajou Univ.)
원제환 (아주의대)
14:30-14:50
Panel discussion
14:50-15:10
Coffee break
Session 4. Drug-based technology in PAD: Issues and solutions
15:10-16:20
Moderators:
Sang Joon Kim (Professor Emeritus, Seoul National Univ.)
김상준 (서울의대)
Hwan Jun Jae (Seoul National Univ.)
제환준 (서울의대)

15:10-15:20
One year since the DCB issue: what's the current evidence
Suh Min Kim (Chung-Ang Univ.)
김서민 (중앙의대)
15:20-15:30
Pharmacology and toxicity of Paclitaxel: what's the influence?
Seung Woon Rha (Korea Univ.)
나승운 (고려의대)
15:30-15:40
Is the increase in patency of drug-based technology justifiable in terms of cost-effectiveness?
Chang-Hwan Yoon (Seoul National Univ.)
윤창환 (서울의대)
15:40-15:50
Updates on drug-based technology for BTK intervention
Jae Hwan Lee (Chungnam National Univ.)
이재환 (충남의대)
15:50-16:00
Strategies to improve drug-delivery efficiency in the SFA: are we dealing aggressively enough with the calcium burden?
Jang Yong Kim (Catholic Univ.)
김장용 (가톨릭의대)
16:00-16:20
Panel discussion
Session 5. The Aorta Essentials
16:20-18:00
Moderators:
Young-wook Kim (Sungkyunkwan Univ.)
김영욱 (성균관의대)
Yong-Pil Cho (Ulsan Univ.)
조용필 (서울아산병원)

16:20-16:30
Recorded live case 4: Late open conversion after EVAR
16:30-17:00
Debate: Lowering the diameter threshold of EVAR to less than 5.5 cm
1. Yes, an overstreched spring never comes back
Kwang Hun Lee (Yonsei Univ.)
이광훈 (연세의대)
2. No, that is not evidence-based or cost-effective
Sang Su Lee (Pusan National Univ.)
이상수 (부산의대)
17:00-17:10
Updates in medical treatment of AAA: the same old guys or any new kids on the stage?
Jin Mo Kang (Gachon Univ.)
강진모 (가천의대)
17:10-17:20
Implications of the NICE guideline: should all elective AAAs be treated surgically?
Seung Kee Min (Seoul National Univ.)
민승기 (서울의대)
17:20-17:30
Unveiling sac biology: Rapid sac growth phenomenon after EVAR compared to untreated natural AAA - What's the implication?
Jin Hyun Joh (Kyung Hee Univ.)
조진현 (경희의대)
17:30-17:40
Late ruptures of AAA after EVAR
Seung Huh (Kyungpook National Univ.)
허승 (경북의대)
17:40-17:50
EVAR for ruptured AAA: ways to increase implementation.
Sun Cheol Park (Catholic Univ.)
박순철 (가톨릭의대)
17:50-18:00
Panel discussion
18:00-00:00
Closing Remarks
 
top